Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
4.380
-0.020 (-0.45%)
At close: Mar 17, 2026, 4:00 PM EDT
4.399
+0.019 (0.43%)
After-hours: Mar 17, 2026, 7:23 PM EDT
Larimar Therapeutics Employees
Larimar Therapeutics had 65 employees as of December 31, 2024. The number of employees increased by 23 or 54.76% compared to the previous year.
Employees
65
Change (1Y)
23
Growth (1Y)
54.76%
Revenue / Employee
n/a
Profits / Employee
-$2,030,754
Market Cap
374.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 65 | 23 | 54.76% |
| Dec 31, 2023 | 42 | 16 | 61.54% |
| Dec 31, 2022 | 26 | -5 | -16.13% |
| Dec 31, 2021 | 31 | 3 | 10.71% |
| Dec 31, 2020 | 28 | 12 | 75.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Ginkgo Bioworks Holdings | 485 |
| Kyverna Therapeutics | 129 |
| Niagen Bioscience | 117 |
| Lineage Cell Therapeutics | 77 |
| Armata Pharmaceuticals | 60 |
| PureTech Health | 56 |
| Zura Bio | 30 |
LRMR News
- 13 days ago - Larimar Therapeutics to Participate in Upcoming Investor Conferences in March - GlobeNewsWire
- 20 days ago - Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering - GlobeNewsWire
- 20 days ago - Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering - GlobeNewsWire
- 20 days ago - Laminar Therapeutics Stock Is Popping Today: What's Going On? - Benzinga
- 21 days ago - Larimar Therapeutics (LRMR) Surges On FDA Breakthrough Therapy Designation - Benzinga
- 21 days ago - Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026 - GlobeNewsWire
- 2 months ago - Larimar Therapeutics: The Market Is Mispricing A Potential Standard Of Care - Seeking Alpha
- 2 months ago - Larimar Therapeutics, Inc. (LRMR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha